Was the flu drug zanamivir a breakthrough or money for old rope?: While Relenza's benefits are modest at best, its story would make a great Hollywood blockbuster

Ray Moynihan

doi:10.1136/bmj.g3611

Was the flu drug zanamivir a breakthrough or money for old rope? While Relenza's benefits are modest at best, its story would make a great Hollywood blockbuster

Ray Moynihan^*

^*Corresponding author for this work

Institute for Evidence-Based Healthcare

Research output: Contribution to journal › Comment/debate/opinion › Research › peer-review

2 Citations (Scopus)

Original language	English
Article number	g3611
Number of pages	2
Journal	British Medical Journal
Volume	348
DOIs	https://doi.org/10.1136/bmj.g3611
Publication status	Published - 2 Jun 2014

Access to Document

10.1136/bmj.g3611

Cite this

@article{6dde79d9a2bb4ed98c818f3a2882c8f6,

title = "Was the flu drug zanamivir a breakthrough or money for old rope?: While Relenza's benefits are modest at best, its story would make a great Hollywood blockbuster",

author = "Ray Moynihan",

year = "2014",

month = jun,

day = "2",

doi = "10.1136/bmj.g3611",

language = "English",

volume = "348",

journal = "British Medical Journal",

issn = "0959-8146",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Was the flu drug zanamivir a breakthrough or money for old rope?

T2 - While Relenza's benefits are modest at best, its story would make a great Hollywood blockbuster

AU - Moynihan, Ray

PY - 2014/6/2

Y1 - 2014/6/2

UR - https://www.scopus.com/pages/publications/84902149171

U2 - 10.1136/bmj.g3611

DO - 10.1136/bmj.g3611

M3 - Comment/debate/opinion

C2 - MEDLINE:24891329

AN - SCOPUS:84902149171

SN - 0959-8146

VL - 348

JO - British Medical Journal

JF - British Medical Journal

M1 - g3611

ER -

Was the flu drug zanamivir a breakthrough or money for old rope? While Relenza's benefits are modest at best, its story would make a great Hollywood blockbuster

Access to Document

Other files and links

Preventing Overdiagnosis

Cite this

Was the flu drug zanamivir a breakthrough or money for old rope? While Relenza's benefits are modest at best, its story would make a great Hollywood blockbuster

Access to Document

Other files and links

Student theses

Preventing Overdiagnosis

Cite this